Business
Exit Playbook, FDA Priority Review, Shutdown Markets, Earnings, Benefits
Today (2025-10-02), we focus on founder exit decisions amid new QSBS rules, a pediatric Priority Review that sets a clear biotech catalyst, initial market moves around the U.S. shutdown, how to trade earnings surprises with discipline, and a notable employer benefits partnership expanding mental-health access. Founder Exit Decision Factors